Cassava Sciences, Inc. (SAVA)
2.93
-0.22
(-6.98%)
USD |
NASDAQ |
Dec 12, 16:00
3.00
+0.07
(+2.39%)
After-Hours: 20:00
Cassava Sciences Research and Development Expense (Quarterly): 3.955M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biogen, Inc. | 369.60M |
| Geron Corp. | 21.07M |
| Ovid Therapeutics, Inc. | 5.853M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 2.526M |